Writing in the current online issue of the journal Stem Cells and Development, researchers at University of California San Diego School of Medicine describe development of a rapid, cost-effective method to create human cortical organoids directly from primary cells.
University of California San Diego and Deerfield Management announce today the creation of Poseidon Innovation, LLC to advance disease-curing therapeutics. Through Deerfield’s $65-million commitment in Poseidon, UC San Diego investigators will have the funding and support to weather risky early-stage…
Engineers have developed neutrophil “nanosponges” that can safely absorb and neutralize a variety of proteins that play a role in the progression of rheumatoid arthritis. Injections of these nanosponges effectively treated severe rheumatoid arthritis in two mouse models. Administering the nanosponges…
Researchers at the San Diego Supercomputer Center (SDSC), an Organized Research Unit of UC San Diego, have been awarded a three-year National Science Foundation (NSF) grant worth more than $818,000 to design and develop cyberinfrastructure that allows researchers to efficiently share information about…
Over the next five years, the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, will award approximately $20 million to four academic centers to launch a new national Career Development Consortium for Excellence in Glycosciences.
Writing in advance of the September 15 issue of Neural Computation, Beatrice Golomb, MD, PhD, professor of medicine at University of California San Diego School of Medicine, says publicly reported symptoms and experiences of a “mystery illness” afflicting American and Canadian diplomats in Cuba and…
A new study led by scientists at Scripps Institution of Oceanography at the University of California San Diego and the Coral Reef Research Foundation (CRRF) in Palau describes a novel approach for predicting warm temperature-induced stress on corals from the sea surface through a deeper expanse ranging…
Researchers at University of California San Diego School of Medicine have launched a phase Ib clinical trial to assess the safety and tolerability of cirmtuzumab, in combination with standard chemotherapy, to treat metastatic or locally advanced breast cancer that cannot be surgically removed.
To better understand how much marijuana or constituent compounds actually get into breast milk and how long it remains, researchers at University of California San Diego School of Medicine conducted a study, publishing online in Pediatrics.
The CIPRES science gateway, which supports major discoveries about evolutionary relationships among our planet’s living creatures, has been awarded grants from the National Science Foundation (NSF) and the National Institutes of Health (NIH) that will provide more than $2.8 million to sustain and enhance…